Flexible and Semi-Rigid Ureteroscopy Market Revenue to Attain USD 3.09 Bn by 2035

Flexible and Semi-Rigid Ureteroscopy Market Revenue and Trends 2026 to 2035

The global flexible and semi-rigid ureteroscopy market revenue surpassed USD 1.50 billion in 2025 and is predicted to attain around USD 3.09 billion by 2035, growing at a CAGR of 7.50%. As more kidney stone cases are being diagnosed, hospitals are increasingly adopting minimally invasive procedures to improve treatment efficiency and patient outcomes, which drives the market.

Market at a Glance

The flexible and semi-rigid ureteroscopy market comprises various endoscopic techniques to measure, visualize, and treat urinary tract conditions, such as kidney stones and ureteral blockages. It involves reusable and disposable ureteroscopes, along with imaging systems and ancillary instruments, that facilitate interventions without making external cuts.

This market spans the entire procedural ecosystem, as clinicians increasingly prefer precision techniques that offer shorter recovery times and lower infection risks across both hospital and outpatient settings. Flexible and semi-rigid ureteroscopy continues to evolve with advancements in devices and accessories, supporting wider adoption for stone management and diagnostic evaluation of conditions such as ureteritis.

Market Forecast

Rise in AI-Integrated Technology

New-generation ureteroscopy devices, including AI-driven devices, are enhancing not only visual precision but also procedural intelligence. The FDA-approved LithoVue™ Elite enables real-time intrarenal pressure monitoring, allowing clinicians to make more informed, dynamic decisions during surgery.

Increase in Procedural Volume

The rising prevalence of kidney stones, which affects nearly 10% of the population, continues to drive steady demand for ureteroscopy procedures. Urolithiasis accounts for over 63% of ureteroscope usage, making it the primary revenue-generating indication in this market.

Ureteroscopy Procedure Trends and Outcomes Data

• A national dataset from England reported 71,305 ureteroscopy procedures over seven years, indicating that the intervention is performed consistently across healthcare systems rather than intermittently.
• The average patient age of 55 years suggests that ureteroscopy primarily addresses conditions in working-age adults.
• The majority of cases were elective (81%), reflecting planned and predictable surgical care, while 45% were performed in outpatient settings, highlighting a gradual shift toward day-surgery models.
• Clinical outcomes remained favorable, with a 6.8% infection rate, 0.5% requiring critical intervention, and a very low mortality rate of 0.18%, demonstrating that increased procedure volumes do not significantly elevate clinical risk.

Market Segmentation Overview

• By product type, the flexible ureteroscopes segment held a 60% share of the flexible & semi-rigid ureteroscopy market in 2025. This is because of their superior maneuverability and superior visualization capabilities, coupled with improved patient comfort during procedures, which made them less of a tool and more of a preferred extension of modern minimally invasive urology.
• By product type, the semi-rigid ureteroscopes segment held the second-largest market share of 40% in 2025 and is expected to grow at the fastest rate in the coming years because of their structural durability and consistent performance in accessing lower ureter regions. Their robustness provides a practical advantage in routine procedures where flexibility is less critical but precise procedural control remains essential.
• By application, the kidney stones treatment segment held a major revenue share of 50% in the market in 2025, driven by the rising incidence of kidney stone cases and advancements in minimally invasive treatment techniques. Increasing patient preference for faster recovery, along with improved clinical protocols, has further strengthened the dominance of this segment.
• By application, the urinary tract infection (UTI) treatment segment is the second-largest shareholder with 20.0% market share in 2025, supported by the growing prevalence of UTIs, particularly among women. Ureteroscopy, originally focused on stone management, is increasingly being utilized for accurate diagnosis and broader urological treatment applications, expanding its clinical relevance.
• By end-use, the hospitals segment accounted for the largest share of 60% in the flexible & semi-rigid ureteroscopy market in 2025, driven by the rising volume of urological surgeries and the availability of advanced treatment infrastructure. Their ability to manage complex cases and integrate sophisticated imaging technologies ensures that most ureteroscopy procedures remain concentrated in hospital settings.
• By end-use, the specialized urology clinics segment is the second-largest shareholder and is expected to grow at a significant rate during the projection period, supported by their focus on advanced, targeted treatments for kidney stones and other urological conditions. Their expansion reflects a gradual shift toward decentralization of care, where expertise-driven outpatient centers are increasingly handling routine procedures.

Regional Insights

North America dominated the flexible & semi-rigid ureteroscopy market with a market share of 35% in 2025, driven by high healthcare standards, early adoption of advanced urological procedures, and a rising prevalence of kidney stone cases. Strong reimbursement frameworks and a well-established preference for minimally invasive surgeries further supported regional demand. The U.S. held the largest share due to widespread adoption of digital and disposable ureteroscopes, while Canada contributed through the expansion of outpatient urology services and increased investment in specialized surgical infrastructure.

Asia Pacific is expected to grow at the fastest CAGR over the forecast period, driven by rapid urbanization, improved access to healthcare services, and a rising prevalence of urological disorders linked to lifestyle and dietary changes. Increasing awareness of minimally invasive stone management is also expected to boost procedural volumes across the region. China is likely to lead the regional market through ongoing hospital modernization, while India continues to expand rapidly with the growth of private healthcare networks and rising demand for cost-effective urological treatments.

Flexible & Semi-Rigid Ureteroscopy Market Coverage

Top Companies in the Flexible & Semi-Rigid Ureteroscopy Market

Companies such as Boston Scientific Corporation, Medtronic PLC, and Olympus Corporation lead the market with broad product portfolios and continuous investments in digital visualization and single-use technologies. Alongside them, Karl Storz SE & Co. KG and Richard Wolf GmbH maintain strong positions through precision-engineered endoscopy systems that have long been associated with surgical reliability. Meanwhile, Stryker Corporation, B. Braun Melsungen AG, and Cook Medical Inc. operate at the intersection of devices and procedural ecosystems, strengthening their presence through integrated and procedure-oriented solutions.

Segments Covered in the Report

By Product Type

• Flexible Ureteroscopes
• Semi-Rigid Ureteroscopes

By Application

• Kidney Stones Treatment
• Urinary Tract Infections (UTI) Treatment
• Bladder Tumors Treatment
• Others

By End-Use

• Hospitals
• Specialized Urology Clinics
• Ambulatory Surgery Centers (ASCs)
• Others

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8301

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344